Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Ken Kato reports consulting fees from Bristol Myers Squibb, Merck Sharp & Dohme, BeiGene, Roche, AstraZeneca, and Bayer; honoraria from Ono Pharmaceuticals, Bristol Myers Squibb, and Taiho; research funding from Ono Pharmaceuticals, Bristol Myers Squibb, Merck Sharp & Dohme, BeiGene, Chugai, Shionogi, AstraZeneca, and Bayer for research subjects outside the submitted work. Shota Igaue, Ryoko Nozaki, Daichi Utsunomiya, Yuto Kubo, Kentaro Kubo, Daisuke Kurita, Shun Yamamoto, Koshiro Ishiyama, Junya Oguma, and Hiroyuki Daiko have no conflicts of interest to declare in relation to this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Igaue, S., Nozaki, R., Utsunomiya, D. et al. ASO Visual Abstract: Significance of Surgery for Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma in the Era of Neoadjuvant Treatment. Ann Surg Oncol 31, 1589–1590 (2024). https://doi.org/10.1245/s10434-023-14754-z
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14754-z